CyberTech Corporation. One of the largest multinational megacompanies of today. With a number of employees reaching far into the hundreds of thousands, split between its three branches, one can truly wonder how much power these people have.
The megacompany could be traced to its roots in 2004, where it began as a small, privately funded Research and Development company holding a number of contracts with DARPA and the CDC. With some of its contracts successful, it grew over the time until 2008, when the company board decided to add in a security sector to protect its employees, rather than to depend on hiring security firms. With the new addition, the company had suddenly increased once again, which allowed it to expand even more.
By 2010, it had connections in over 30 different countries, working on contracts with a multitude of government agencies, and the success of each contract expanded the company even further. While a viral outbreak had occurred in New York in 2012, it had taken roughly 2 months before the incident was contained and wiped, which started up a new program within the corporate's portfolios: Biological Defense.
By 2016, CyberTech had spread over into contact with over 140 countries, supplying military and government agencies with technology developed by them. It wasn't until 2025, when CyberTech made its most powerful move on the corporate chessboard.
2025 was the year when CyberTech, with the massive amounts of funds coming in from stocks, began to privately fund both law enforcement and government agencies, not to just pay back what the governments done for them, but to also move the company forward, effectively becoming a major player in the security field.
Since 2030, the company had continued to grow larger, as it continued its research in multiple fields, even to the point of eradicating multiple diseases and conditions from the face of the Earth, with HIV/AIDS and multiple forms of cancer being no more. It became the first company to design the first operational prototype of a combat variant of an exoskeletal suit, further increasing their foothold on the robotics field.
After the outbreak a year ago, CyberTech found itself interested into the virus, allocating larger resource pools to both its Research and Security branches. They've been tasked with engineering a counteragent, a cure to reverse the deadly and mutative effects. It was only recently, that they were on the verge of success of developing a working cure, when the facility responsible for the feat went silent and any security teams sent to investigate mysteriously disappearing without a whisper...